BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Oncoteq
/
Mads Dalsgaard
MD
Mads Dalsgaard
Chief Executive Officer
Oncoteq
Therapeutic Areas
Oncology
Oncoteq Pipeline
Drug
Indication
Phase
TEQ102 (formerly TUB-010)
Oncology (unspecified)
Preclinical/Phase 1